Cell lines MDA-MB-231 (HTB-26), MCF-10A (CRL-10317), MCF-7 (HTB-22), BT-474 (HTB-20), BT-20 (HTB-19), HL-60 (CCL-240), LN-229 (CRL-2611), and SK-BR-3 (HTB-30) were purchased from ATCC, Manassas, VA, USA.
Antibodies anti-b-actin, anti-CB1, anti-CB2, and anti-GPR55 were from Abcam, Cambridge, UK. Anti-mouse IgG antibody was from Jackson ImmunoResearch, Cambridge, UK.
SR 144028, PSB CB5, ML-184, ML-193, and LPI were from Tocris Bioscience, Bristol, UK. DMSO, resazurin, NAD+, DL-lactate, diaphorase, iodonitrotetrazolium chloride (INT), D-glucose, glycylglycine, acetic acid, MgSO4, EGTA, dithiothreitol, DMSO, Triton X-100, acrylamide, bis-acrylamide, Triton X-100, SDS, nitro blue tetrazolium, Tris, EDTA, agarose, bicinchoninic acid, D-glucose, bovine serum albumin, anti-rabbit IgG antibody, and 5-Bromo-4-chloro-3-indolyl phosphate-toluidine were from Sigma-Aldrich, St. Louis, MO, USA. The purity of all used reagents was 95% or more.
rhEGF was from SciStoreLab, Skolkovo, Russia.